Breakthrough bleeding with oral contraceptive use

DOI: https://doi.org/10.29296/25877305-2018-08-09
Download full text PDF
Issue: 
8
Year: 
2018

Professor M. Savelyeva(1), MD; Z. Nesterenko(2); A. Alekseeva(2); B. Tachieva(2) 1-Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia, Moscow 2-I.M. Sechenov First Moscow State Medical University (Sechenov University)

A questioning method was used to investigate the prevalence of breakthrough bleeding in reproductive-aged women taking combined oral contraceptives.
Keywords: 
oral contraceptives
breakthrough bleeding
combined oral contraceptives
ethinyl estradiol
cytochrome P-450

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Weisberg E. A chewable low-dose oral contraceptive: a new birth control option? // Patient Prefer. Adherence. – 2012; 6: 355–60.
  2. Jensen J., Bitzer J., Serrani M. Comparison of the pharmacologic and clinical profiles of new combined oral contraceptives containing estradiol // Open Access J. Contracept. – 2013; 4: 39–50.
  3. Black A., Francoeur D., Rowe T. et al. Canadian Contraception Consensus. SOGC Clinical Practice Guidelines, No.143-part 1, February 2004 // J. Obstet. Gynaecol. Can. – 2004; 26 (2): 143–56.
  4. Smetnik V.P. Estrogeny: ot sinteza do klinicheskogo primenenija / M.: Prakticheskaja meditsina, 2012; s. 176.
  5. Grandi G., Napolitano A., Cagnacci A. Metabolic impact of combined hormonal contraceptives containing estradiol // Exp. Opin. Drug Metab. Toxicol. – 2016; 12: 779–87.
  6. Kuhl H. Pharmacology of estrogens and progestogens: influence of different routes of administration // Climacteric. – 2005; 8 (Suppl. 1): 3–63.
  7. Jeyakumar M., Carlson K., Gunther J. et al. Exploration of dimensions of estrogen potency: parsing ligand binding and coactivator binding affinities // J. Biol. Chem. – 2011; 286: 12971–82.
  8. Gosudarstvennyj reestr lekarstvennyh sredstv. [Elektronnyj resurs] URL: http://grls.rosminzdrav.ru/ (data obraschenija 15.11.2017).
  9. Bořek-Dohalská L., Valášková P., Černá V. et al. Role of rat cytochromes P450 in the oxidation of 17α-ethinylestradiol // Environ. Toxicol. Pharmacol. – 2014; 38 (3): 852–60.
  10. World Health Organization (WHO). Medical eligibility criteria for contraceptive use. 4th ed. / Geneva, Switzerland: WHO; 2009.
  11. Savel'eva G.M., Suhih G.T., Serova V.N. i dr. Ginekologija. Natsional'noe rukovodstvo / M.: GEOTAR-Media, 2017; s. 1048.
  12. Black A., Francoeur D., Rowe T. et al. Canadian Contraception Consensus. SOGC Clinical Practice Guidelines, No.329-part 4, April 2017 // J. Obstet. Gynaecol. Can. – 2017; 39 (4): 22968.
  13. Hapangama D., Bulmer J. Pathophysiology of heavy menstrual bleeding. // Womens Health (Lond). – 2016; 12: 3–13.
  14. Savel'eva M.I., Nesterenko Z.A., Alekseeva A.Ju. Rol' kombinirovannyh peroral'nyh kontratseptivov v patogeneze mezhmenstrual'nyh krovotechenij // Novye zadachi sovremennoj meditsiny. – 2016; 53–5.